Shaping the future of patient care.
From a panel discussion to podium and workshop presentations, EVERSANA shared insight at this year’s virtual ISPOR 2020 conference. More than 1,300 attended the conference from 54 countries; and our experts demonstrated the impact of comprehensive HEOR capabilities, including economic modeling, evidence synthesis, value communication and reimbursement strategies, across all stages of the product lifecycle.
Below is an overview of our participation, and each links to a downloadable PDF presentation. It represents the breadth of the value we bring in helping shape the future of patient care.
- Chris Cameron – WORKSHOP: Developing and Implementing an Indirect Treatment Comparison Program to Support Global HTA and Reimbursement Submissions
- Nicole Ferko – PANEL: Are Existing Regulatory Evidence Standards Adequate for Informing Decisions Medical Device Adoption by US Healthcare Providers/Hospitals?
- Tim Disher – PODIUM: Methodological Challenges With Conducting Network Meta-Analyses Assessing Long-term Comparative Efficacy in Psoriasis
- Rana Qadeer – PODIUM: Application of Propensity Score Matching and Bayesian Hierarchical Design Methods to Integrate Single-Arm Studies Into Network Meta-Analyses (NMAs): Opportunities and Pitfalls Illustrated in a Case Study assessing Ablation/Radiation Therapies in Lung Cancer
Our experts also submitted 14 posters covering health economic evidence, comparative economic analysis, economic modeling and real-world evidence across a variety of therapeutic areas.
Click on the above links to download the presentations. Click here to learn more about the work we do and to explore our library.
Talk with our experts.
EVERSANA employs a team of over 2500 professionals across 27 locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter the most to our clients and perform superior services that create value across the product life cycle.